Fidelity Advisor Biotechnology Fund (FBTTX)
Fidelity Advisor Biotechnology Fund operates in the Asset Management industry of the Financial Services sector, headquartered in Boston, MA, US. The stock last traded at $42.35, down 0.54% on the session, giving a market capitalisation of $2.22B. Its beta of 0.62 implies it has historically moved less than the broad market.
This fund primarily allocates its capital to common equities. A substantial portion, specifically at least 80% of its total assets, is dedicated to companies deeply involved in the biotechnology industry. This encompasses businesses engaged in the research, development, manufacturing, and distribution of biotechnological products, services, and processes, as well as those poised to benefit significantly from scientific and technological advancements in the field. Its investments span both domestic and international issuers. To select holdings, the fund employs a rigorous fundamental analysis, evaluating factors such as each company's financial strength, its competitive position within its industry, and broader market and economic conditions. It operates as a non-diversified fund.
Fidelity Advisor Biotechnology Fund is most often compared with the following Financial Services names: